"Strattera,
New ADHD Medication" The newest ADHD medication Strattera (atomoxetine) is expected to hit pharmacy shelves this month to much ado. What separates Strattera (atomoxetine) from rest of ADHD medications pack is that Strattera (atomoxetine) is first non-stimulant medication FDA-approved for Attention Deficit Disorder. Strattera (atomoxetine) is not a controlled substance under Controlled Substance Act, which translates to convenience of phone-in refills and less prescription hassles at pharmacy. Strattera (atomoxetine) is an oral capsule prescribed in a once or twice daily dose, which also eliminates need for school children to medicate during school day. And, Strattera (atomoxetine) is only ADHD medication FDA-approved for adults. But before you knock on your doctor's door asking for a prescription, there are a few things you should know about this new ADHD medication. Although Strattera (atomoxetine) is a non-stimulant ADHD medication, it still poses many side effects consistent with side effects of other ADHD medications - and a few new ones that adults might find less than pleasant.
Common Strattera (atomoxetine) Side Effects include (but not limited to): _ Problems sleeping/Insomnia _ Dry mouth _ Decreased appetite _ Weight loss _ Upset stomach _ Constipation _ Nausea and/or vomiting _ Dizziness _ Tiredness _ Mood swings _ Ear infection _ Influenza _ Irritability
Sexual side effects (in adults studied): _ Decreased libido _ Ejaculatory problems _ Impotence _ Urination problems _ Painful menstrual periods
The following, though rare, have also been reported: _ Strattera (atomoxetine) can cause potentially serious allergic reactions.
Strattera (atomoxetine) can increase heart rate and blood pressure. Strattera (atomoxetine) can also worsen conditions of high blood pressure and heart disease. Strattera (atomoxetine) should not be taken at same time as, or within two weeks of taking, a monoamine oxidase inhibitor. Patients with narrow angle glaucoma should not take Strattera (atomoxetine).
You should alert prescribing physician of following condition before beginning Strattera (atomoxetine); _ Current or past depression, psychosis or other mental conditions _ Alcohol or drug abuse _ Heart disease _ High blood pressure _ Epilepsy or seizure disorders _ Liver disease or kidney disease _ Pregnancy, nursing or plans to become pregnant
Strattera (atomoxetine) makers Eli Lilly and Company conducted six placebo-controlled studies in children, adolescents and adults for FDA submission. Early studies suggest that potential of abuse is lower with Strattera (atomoxetine) and side effects may not be as pronounced as with other ADHD medications.
